National and Kapodistrian University of Athens
Ο ρόλος των μικροκυστιδίων στα οξέα στεφανιαία σύνδρομα: συσχέτιση με τη φλεγμονή, την πήξη και την ενδοθηλιακή λειτουργία
Abstract
dc:descriptionIntroduction: Circulating microvesicles (MV), which are derived from blood cells and endothelial cells, have been considered surrogate markers of atherosclerosis. However, their role in acute coronary syndromes (ACS) has not been fully elucidated yet, while most of the data stem from the apoptotic, phosphatidylserine positive (PS+) microvesicles. The present study aims to examine the role of the association of circulating MVs with ACS pathophysiology and to compare the roles of apoptotic (PS+) and non-apoptotic (PS-) circulating microvesicles in patients with ACS. Methods: One hundred and fifty-three patients (n=153) were included in the study; 49 patients with ST-elevation myocardial infarction (STEMI), 35 with non-STEMI (NSTEMI), 38 with unstable angina, 15 with stable coronary artery disease and 16 control individuals. Flow cytometry analysis was used to quantify circulating apoptotic/non-apoptotic (phospatidyloserine+/phospatidyloserine-) endothelial cell (EMV), red blood cell (RMV) and platelet (PMV) derived MV. Flow-mediated dilatation (FMD) of the brachial artery was assessed by ultrasound to estimate endothelial function. The inflammatory profile was assessed by serum C-reactive protein (hsCRP) and ST-2 levels. The plasma thrombotic profile was assessed by measurement of the fibrinogen and D-dimers. The extent of myocardial damage was estimated by the peak high sensitivity troponin- I levels. The patients underwent coronary angiography and/or angioplasty, where indicated, according to the guidelines. The angiographic data and GENSINI scores were recorded and calculated. The patients were followed-up for 18 months. Results: Apoptotic MV were increased in patients with ACS (EMV, P=2.32x10-9; RMV, P=.0019; PMV, P=0.01), whereas but no similar increase was noted for the non-apoptotic MV. Hierarchical clustering of the total population of ACS patients (n=122) by circulating levels of phospatidyloserine+ EMV, RMV and PMV identified two discreet clusters of patients without any differences in traditional risk factors, but significant differences in brachial FMD (5.2% (2.5) vs. 4.1% (2.3), P<.05) that remained significant after adjustment for co-variates. The prevalence of STEMI, a surrogate for plaque rupture and vessel thrombotic occlusion, was significantly higher in the patient cluster with impaired endothelial function, which was the cluster with the higher levels of apoptotic MV (60% vs 32%, P=.016, adjusted odds ratio for STEMI, 3.041, 95%CI, 1.160 to 7.968, p=.024). Moreover, the patients with higher levels of PS+MV had a higher inflammatory status and a higher burden of atherosclerotic coronary lesions. On the contrary, the levels of PS-MV were negatively correlated with the levels of the inflammatory biomarkers and the extent of myocardial damage. Both PS+ and PS-MV were negatively correlated with the levels of fibrinogen. The patients with “higher levels of non apoptotic EMV” had decreased prevalence for death and or readmissions (19.6% vs 39,6%) and a longer event-free survival (15.8 vs 13.7 months) compared to patients with «lower levels of non-apoptotic EMV» (p=0.0310). Additionally, patients with a “profile of non-apoptotiv EMV” had a decreased prevalence for the cumulative event of death and or readmission for cardiovascular causes (9.5 vs 34.6%) and a longer event-free survival (17.3 vs 14 months) compared to patients with a “profile of apoptotic EMV” (p=0.022). The findings regarding RMV were similar. Conclusions: The present study showed, for the first time to the best of our knowledge, the differences between the apoptotic and non-apoptotic microvesicles in patients with Acute Coronary Syndromes. Previously, microvesicles had been linked to detrimental effects in patients with atherosclerosis. The present study showed that only the subpopulation of apoptotic microvesicles seems to be linked to the adverse cardiovascular effects seen in patients with atherosclerosis. On the contrary, non-apoptotic microvesicles seem to exert a protective role in these patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zacharia, Effimia-Maria
- Ζαχαρία, Ευφημία-Μαρία
Subjects
dc:subject × 37- Μικροκυστίδια
- Μικροσωματίδια
- Οξέα στεφανιαία σύνδρομα
- Οξύ έμφραγμα μυοκαρδίου
- ΑΝΑΣΠΑΣΗ ST ΔΙΑΣΤΗΜΑΤΟΣ
- Έμφραγμα χωρίς ανάσπαση του ST
- Ασταθής στηθάγχη
- Ενδοθηλιακά μικροσωματίδια
- Αιμοπεταλιακά μικροσωματίδια
- Ερυθροκυτταρικά μικροσωματίδια
- Αποπτωτικά μικροσωματίδια
- Ενδοθηλιακή δυσλειτουργία
- Ρήξη αθηρωματικής πλάκας
- Φλεγμονή και ενδοθηλιακή δυσλειτουργία
- Διαταραχές πήξης
- Μοντέλο πρόγνωσης θνητότητας
- Microvesicles
- Microparticles
- Acute coronary syndromes
- Non ST elevation myocardial infarction
- ST SEGMENT ELEVATION
- Unstable angina
- Endothelial microparticles
- Platelet-derived microparticles
- Red blood cell microparticles
- Apoptotic microparticles
- Endothelial dysfunction
- Atheromatic plaque rupture
- Inflammation and endothelial dysfunction
- Coagulation disturbance
- Prognosis - survival
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επαγγέλματα υγείας
- Health Sciences
- Medical and Health Sciences
- Health Professions
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/52152